Institutional Ownership
Neurosense Therapeutics Ltd
CUSIP M74240108ORDINARY SHARESQ1 2026
13D / 13G Filings
10
Schedule 13D/13G on record
Beneficial Filers
5
Distinct reporting persons
Largest Stake
27.4%
Max % of class reported
Institutional Holders
13
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
10 filings · latest Dec 9, 2024
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Dec 9, 2024 | Rimon Gold Assets Ltd | 13G | 10.0% | 2.30M | SEC |
| 2 | Feb 13, 2024 | Gordon Ariel | 13G/A | 6.9% | 1.06M | SEC |
| 3 | Feb 13, 2024 | Ben-Noon Alon | 13G/A | 20.0% | 3.07M | SEC |
| 4 | Apr 5, 2023 | Ben-Noon Alon | 13G/A | 25.8% | 3.04M | SEC |
| 5 | Mar 15, 2023 | Gordon Ariel | 13G/A | 8.9% | 1.05M | SEC |
| 6 | Mar 15, 2023 | E Europe Ltd | 13G/A | — | — | SEC |
| 7 | Mar 15, 2023 | Real Property International Ltd | 13G | 3.8% | 452.5K | SEC |
| 8 | Dec 30, 2021 | E Europe Ltd | 13G | 5.5% | 602.5K | SEC |
| 9 | Dec 23, 2021 | Ben-Noon Alon | 13G | 27.4% | 3.00M | SEC |
| 10 | Dec 20, 2021 | Gordon Ariel | 13G | 9.5% | 1.04M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Yorkville Advisors Global, LP | 78.0K | $58.9K |
| 2 | Independent Advisor Alliance | 50.0K | $37.8K |
| 3 | Ubs Group AG | 49.1K | $37.1K |
| 4 | Two Sigma Investments, LP | 44.4K | $33.6K |
| 5 | Meitav Investment House Ltd | 40.0K | $30.2K |
| 6 | Jane Street Group, LLC | 28.7K | $21.6K |
| 7 | Commonwealth Equity Services, LLC | 22.8K | $17.2K |
| 8 | Pnc Financial Services Group, Inc. | 21.1K | $16.0K |
| 9 | Pathstone Holdings, LLC | 16.5K | $12.5K |
| 10 | Geode Capital Management, LLC | 15.9K | $12.0K |